NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
Curasight fortsætter deres kapitalrejsning, der skal sikre finansiering indtil H2 2025. Kun aktionærer pr. 13. september vil modtage unit rights og dermed TO2 og TO
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. The Danish biotech and healthcare stocks delivered a return of
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. The Kapital Partner Nordic healthcare index declined 0.4%. 8 of
Curasights plan om at levere en kombineret tilgang til både diagnose og behandling accelereres yderligere. Et nyt fase I/II studie, op til MDKK 120 i
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. The Kapital Partner Nordic healthcare index increased 1.9% amid in
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week the Nordic healthcare stocks increased 1.5% despite a
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week the Nordic healthcare stocks fell 3.1%, while the
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week the Nordic healthcare stocks rose 0.6%, while the
Kapital Partner udfører eller har inden for de seneste 12 måneder udført corporate finance, market relations, investor relations, Certified Adviser eller andre rådgivningsaktiviteter for følgende børsnoterede selskaber: CS Medica, EKOBOT AB, Biotech, Ensurge, Lifecare AS, NORD.investments, Biosergen, Hypefactors, Curasight, Re-Match, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.